+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • September 2023
  • 65 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • September 2023
  • 79 Pages
  • Global
From
Crohn's Disease Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Crohn's Disease Epidemiology Analysis and Forecast to 2032

  • Report
  • August 2023
  • 47 Pages
  • Global
From
Primary Immune Deficiency (PID) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Primary Immune Deficiency (PID) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2023
  • 85 Pages
  • Global
From
Psoriatic Arthritis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Psoriatic Arthritis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • May 2023
  • 97 Pages
  • Global
From
Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • April 2023
  • 74 Pages
  • Global
From
Mucopolysaccharidosis II (MPS II) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Mucopolysaccharidosis II (MPS II) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • March 2023
  • 64 Pages
  • Global
From
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 48 Pages
  • Global
From
Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 59 Pages
  • Global
From
Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027 - Product Thumbnail Image

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

  • Report
  • November 2022
  • 119 Pages
  • Global
From
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027 - Product Thumbnail Image

Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027

  • Report
  • November 2022
  • 107 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • October 2022
  • 82 Pages
  • Global
From
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape - Product Thumbnail Image

Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape

  • Report
  • October 2022
  • 60 Pages
  • Global
From
Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • September 2022
  • 176 Pages
  • Global
From
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2022
  • 70 Pages
  • Global
From
Sjogrens Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Sjogrens Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2022
  • 59 Pages
  • Global
From
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • June 2022
  • 62 Pages
  • Global
From
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update - Product Thumbnail Image

Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

  • Report
  • April 2022
  • 58 Pages
  • Global
From
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 - Product Thumbnail Image

Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030

  • Report
  • April 2022
  • 94 Pages
  • Global
From
Eosinophilic Esophagitis - Opportunity Assessment and Forecast to 2030 - Product Thumbnail Image

Eosinophilic Esophagitis - Opportunity Assessment and Forecast to 2030

  • Report
  • December 2021
  • 83 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more